$PSTI breakout $3.37 Website http://www.plur
Post# of 63699
Posted On: 01/28/2015 5:18:08 PM
$PSTI breakout $3.37
Website
88 % Buy
detailed opinion
Shares Outstanding5: 70.08M
Float: 65.73M
% Held by Insiders: 8.61%
% Held by Institutions: 1.50%
Shares Short (as of Dec 31, 2014): 503.53K
Short Ratio (as of Dec 31, 2014): 3.40
Short % of Float (as of Dec 31, 2014): 0.80%
Shares Short (prior month)3: 386.70K
10-Q 11/6/14
Summary
Recent trades
Headlines
Tuesday, January 27, 2015
Updated Coverage Report Focuses on Pluristem TherapeuticsMarketwired (Tue, Jan 27)
Tuesday, January 13, 2015
Pluristem to Present at Two Cell Therapy Conferences in January 2015GlobeNewswire (Tue, Jan 13)
Monday, January 12, 2015
PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Pluristem Issues Letter to ShareholdersGlobeNewswire (Mon, Jan 12)
Tuesday, January 6, 2015
Pluristem Granted Patent for Foundational Cell Harvesting Technology in South AfricaGlobeNewswire (Tue, Jan 6)
Monday, December 22, 2014
New Published Data Show Pluristem's PLX Cells Protect NeuronsGlobeNewswire (Mon, Dec 22)
Thursday, December 4, 2014
Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant OutcomesGlobeNewswire (Thu, Dec 4)
Monday, December 1, 2014
Pluristem Granted Patent in Singapore for Its 3D Cell Expansion TechnologyGlobeNewswire (Mon, Dec 1)
Tuesday, November 25, 2014
Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific ConferencesGlobeNewswire (Tue, Nov 25)
Friday, November 21, 2014
Pluristem posts 1Q lossAP (Fri, Nov 21)
Tuesday, November 18, 2014
PLURISTEM THERAPEUTICS INC FinancialsEDGAR Online Financials (Tue, Nov 18)
Wednesday, November 12, 2014
Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple IndicationsGlobeNewswire (Wed, Nov 12)
Monday, November 10, 2014
Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014GlobeNewswire (Mon, Nov 10)
Thursday, November 6, 2014
PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 6)
Monday, October 27, 2014
The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4%Zacks (Mon, Oct 27)
Tuesday, October 14, 2014
Dynavax Initiates Phase I/II Trial on Lymphoma CandidateZacks (Tue, Oct 14)
Wednesday, October 8, 2014
Can the Uptrend Continue for Pluristem (PSTI)?Zacks (Wed, Oct
Tuesday, October 7, 2014
Sunesis Pharmaceuticals Down on Failure of Trial on QinprezoZacks (Tue, Oct 7)
Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.5%Zacks (Tue, Oct 7)
Monday, October 6, 2014
Incyte Receives $60M Milestone Payment Related to JakaviZacks (Mon, Oct 6)
Website
88 % Buy
detailed opinion
Shares Outstanding5: 70.08M
Float: 65.73M
% Held by Insiders: 8.61%
% Held by Institutions: 1.50%
Shares Short (as of Dec 31, 2014): 503.53K
Short Ratio (as of Dec 31, 2014): 3.40
Short % of Float (as of Dec 31, 2014): 0.80%
Shares Short (prior month)3: 386.70K
10-Q 11/6/14
Summary
Recent trades
Headlines
Tuesday, January 27, 2015
Updated Coverage Report Focuses on Pluristem TherapeuticsMarketwired (Tue, Jan 27)
Tuesday, January 13, 2015
Pluristem to Present at Two Cell Therapy Conferences in January 2015GlobeNewswire (Tue, Jan 13)
Monday, January 12, 2015
PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Pluristem Issues Letter to ShareholdersGlobeNewswire (Mon, Jan 12)
Tuesday, January 6, 2015
Pluristem Granted Patent for Foundational Cell Harvesting Technology in South AfricaGlobeNewswire (Tue, Jan 6)
Monday, December 22, 2014
New Published Data Show Pluristem's PLX Cells Protect NeuronsGlobeNewswire (Mon, Dec 22)
Thursday, December 4, 2014
Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant OutcomesGlobeNewswire (Thu, Dec 4)
Monday, December 1, 2014
Pluristem Granted Patent in Singapore for Its 3D Cell Expansion TechnologyGlobeNewswire (Mon, Dec 1)
Tuesday, November 25, 2014
Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific ConferencesGlobeNewswire (Tue, Nov 25)
Friday, November 21, 2014
Pluristem posts 1Q lossAP (Fri, Nov 21)
Tuesday, November 18, 2014
PLURISTEM THERAPEUTICS INC FinancialsEDGAR Online Financials (Tue, Nov 18)
Wednesday, November 12, 2014
Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple IndicationsGlobeNewswire (Wed, Nov 12)
Monday, November 10, 2014
Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014GlobeNewswire (Mon, Nov 10)
Thursday, November 6, 2014
PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 6)
Monday, October 27, 2014
The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4%Zacks (Mon, Oct 27)
Tuesday, October 14, 2014
Dynavax Initiates Phase I/II Trial on Lymphoma CandidateZacks (Tue, Oct 14)
Wednesday, October 8, 2014
Can the Uptrend Continue for Pluristem (PSTI)?Zacks (Wed, Oct
Tuesday, October 7, 2014
Sunesis Pharmaceuticals Down on Failure of Trial on QinprezoZacks (Tue, Oct 7)
Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.5%Zacks (Tue, Oct 7)
Monday, October 6, 2014
Incyte Receives $60M Milestone Payment Related to JakaviZacks (Mon, Oct 6)
(0)
(0)Scroll down for more posts ▼